IDEAYA Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IDEAYA Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q2 2024.
  • IDEAYA Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.73M, a 106% increase year-over-year.
  • IDEAYA Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $26.1M, a 81.9% increase year-over-year.
  • IDEAYA Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18.5M, a 59% increase from 2022.
  • IDEAYA Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.6M, a 41.2% increase from 2021.
  • IDEAYA Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.24M, a 128% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $26.1M $9.73M +$5M +106% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $21.1M $6.31M +$2.65M +72.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $18.5M $4.8M +$1.82M +61.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $16.7M $5.3M +$2.3M +76.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $14.4M $4.73M +$1.69M +55.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $12.7M $3.66M +$1.05M +40.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $11.6M $2.98M +$912K +44.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $10.7M $3M +$807K +36.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $9.91M $3.04M +$986K +47.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.92M $2.61M +$687K +35.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $8.24M $2.06M +$1.02M +97.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $7.22M $2.2M +$1.22M +124% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6M $2.06M +$1.23M +150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $4.77M $1.92M +$1.16M +153% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.61M $1.05M +$327K +45.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $3.28M $981K +$463K +89.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.82M $824K +$276K +50.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.54M $758K +$375K +97.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.17M $719K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-18
Q3 2019 $518K +$231K +80.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $548K +$322K +142% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $383K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 $287K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $226K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.